Gatti, Milo; Cojutti, Pier Giorgio; Bartoletti, Michele; Tonetti, Tommaso; Bianchini, Amedeo; Ramirez, Stefania; Pizzilli, Giacinto; Ambretti, Simone; Giannella, Maddalena; Mancini, Rita; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients, «CRITICAL CARE», 2022, 26, Article number: 178, pp. 1 - 14 [articolo]Open Access
Raschi, Emanuel; Fusaroli, Michele; Gatti, Milo; Caraceni, Paolo; Poluzzi, Elisabetta; De Ponti, Fabrizio, Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal, «PHARMACEUTICALS», 2022, 15, Article number: 645, pp. 1 - 11 [articolo]Open Access
Mazzitelli, Maria; Gatti, Milo; Scaglione, Vincenzo; Mengato, Daniele; Trevenzoli, Marco; Sattin, Andrea; Pea, Federico; Cattelan, Anna Maria, Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus: A Retrospective Single-Centre Experience, «ANTIBIOTICS», 2022, 11, Article number: 1377, pp. 1 - 9 [articolo]Open Access
Gatti, Milo; Barnini, Simona; Guarracino, Fabio; Parisio, Eva Maria; Spinicci, Michele; Viaggi, Bruno; D'Arienzo, Sara; Forni, Silvia; Galano, Angelo; Gemmi, Fabrizio, Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice, «ANTIBIOTICS», 2022, 11, pp. 1 - 21 [articolo]Open Access
Gatti, Milo; Giannella, Maddalena; Rinaldi, Matteo; Gaibani, Paolo; Viale, Pierluigi; Pea, Federico, Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia, «ANTIBIOTICS», 2022, 11, Article number: 1739, pp. 1 - 10 [articolo]Open Access
Cojutti, Pier Giorgio; Tedeschi, Sara; Gatti, Milo; Zamparini, Eleonora; Meschiari, Marianna; Siega, Paola Della; Mazzitelli, Maria; Soavi, Laura; Binazzi, Raffaella; Erne, Elke Maria; Rizzi, Marco; Cattelan, Anna Maria; Tascini, Carlo; Mussini, Cristina; Viale, Pierluigi; Pea, Federico, Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring, «ANTIBIOTICS», 2022, 11, Article number: 996, pp. 1 - 12 [articolo]Open Access
Gatti M.; Virgili G.; Cojutti P.G.; Gaibani P.; Conti M.; Sturiale C.; Pea F.; Viale P., Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases, «MICROORGANISMS», 2022, 10, Article number: 154, pp. 1 - 8 [articolo]Open Access
Gatti, Milo; Campoli, Caterina; Belotti, Tamara; Cojutti, Pier Giorgio; Masetti, Riccardo; Pession, Andrea; Viale, Pierluigi; Pea, Federico, Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignancies, «THERAPEUTIC DRUG MONITORING», 2022, 44, pp. 641 - 650 [articolo]
Sanz Codina, Maria; Gatti, Milo; Troisi, Carla; Fornaro, Giacomo; Pasquini, Zeno; Trapani, Filippo; Zanoni, Andrea; Caramelli, Fabio; Viale, Pierluigi; Pea, Federico, Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem, «PHARMACEUTICS», 2022, 14, Article number: 1585, pp. 1 - 10 [articolo]Open Access
Cojutti P.G.; Fornaro G.; Gatti M.; Rinaldi M.; Gaibani P.; Giannella M.; Pea F.; Viale P., Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring, «INFECTIOUS DISEASE REPORTS», 2022, 14, pp. 88 - 92 [articolo]Open Access
Gatti, Milo; Pea, Federico, The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical Conditions, «CLINICAL PHARMACOKINETICS», 2022, 61, pp. 1519 - 1544 [articolo]Open Access
Rinaldi, Matteo; Bonazzetti, Cecilia; Gatti, Milo; Caroccia, Natascia; Comai, Giorgia; Ravaioli, Matteo; Morelli, Maria Cristina; Viale, Pierluigi; Giannella, Maddalena, The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis, «TRANSPLANT INFECTIOUS DISEASE», 2022, 24, Article number: e13979, pp. 1 - 12 [articolo]Open Access
Gatti, Milo; Bartoletti, Michele; Cojutti, Pier Giorgio; Gaibani, Paolo; Conti, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2021, 27, pp. 294 - 298 [articolo]Open Access
Gatti M.; Cojutti P.G.; Campoli C.; Caramelli F.; Corvaglia L.T.; Lanari M.; Pession A.; Ramirez S.; Viale P.; Pea F., A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 755075, pp. 1 - 13 [articolo]Open Access
Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi, Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system, «EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY», 2021, 28, Article number: 2047487320915663, pp. 983 - 989 [articolo]Open Access
